RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia
John P. Perentesis(University of Southern California), Leslie L. Robison(St. Jude Children's Research Hospital), William R. Kiffmeyer(University of Minnesota), Eleanor Boyle(Children's Hospital Central California), Ying Shao(Huazhong Agricultural University), J Envall-Fox(University of Minnesota), Xiao‐Ou Shu(Vanderbilt University Medical Center), Harland N. Sather(Children's Oncology Group), Ravi Bhatia(University of Alabama at Birmingham), P S Gaynon(Children's Hospital of Los Angeles), M. Steinbuch(Eindhoven University of Technology)
Cited by 118
Related Papers
Chronic Health Conditions in Adult Survivors of Childhood Cancer
|New England Journal of Medicine|2006|3.6k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
|Journal of Clinical Oncology|1996|914
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
|Nature reviews. Cancer|2013|864